| Dr Dennis Michael Moore, MD | |
|
1875 Dempster, Suite 625, Park Ridge, IL 60068 | |
| (847) 518-1200 | |
| (847) 518-1209 |
| Full Name | Dr Dennis Michael Moore |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 42 Years |
| Location | 1875 Dempster, Park Ridge, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295832483 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0901X | Otolaryngology - Otology & Neurotology | (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Loyola University Medical Center | Maywood, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Loyola University Medical Center | 3779488903 | 863 |
News Archive
Hospitals routinely implement processes aimed at increasing provision of high quality care for patients, such as calling patients to encourage follow-up visits or providing doctors and nurses with alerts in electronic health records to prompt reminders for vaccinations.
Dr. Bruce Bode announced today that he is now recruiting adults with newly diagnosed type 1 diabetes for Protege Encore, a randomized, placebo-controlled Phase III clinical trial. This is the second of two Phase III studies testing the safety and efficacy of an investigational drug called teplizumab. The first study, known as Protege, has completed enrollment of more than 530 subjects with type 1 diabetes.
For patients with the most common form of hepatitis C being treated for the first time, the addition of an investigational hepatitis C-specific protease inhibitor called telaprevir to the current standard therapy markedly improved their sustained viral response (SVR or viral cure) rate.
It's no secret that obesity is a major problem in America. More than one-third of adults and one-sixth of children are obese and it is one of the leading causes of preventable death. The costs associated with obesity are estimated at $99 million annually, comparable to the economic toll of cigarette smoking.
When it comes to being short of breath during exercise, how fat is distributed on the body is a more significant factor than overall body fatness or lung function
› Verified 7 days ago
| Entity Name | Loyola University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336159961 PECOS PAC ID: 3779488903 Enrollment ID: O20031202000027 |
News Archive
Hospitals routinely implement processes aimed at increasing provision of high quality care for patients, such as calling patients to encourage follow-up visits or providing doctors and nurses with alerts in electronic health records to prompt reminders for vaccinations.
Dr. Bruce Bode announced today that he is now recruiting adults with newly diagnosed type 1 diabetes for Protege Encore, a randomized, placebo-controlled Phase III clinical trial. This is the second of two Phase III studies testing the safety and efficacy of an investigational drug called teplizumab. The first study, known as Protege, has completed enrollment of more than 530 subjects with type 1 diabetes.
For patients with the most common form of hepatitis C being treated for the first time, the addition of an investigational hepatitis C-specific protease inhibitor called telaprevir to the current standard therapy markedly improved their sustained viral response (SVR or viral cure) rate.
It's no secret that obesity is a major problem in America. More than one-third of adults and one-sixth of children are obese and it is one of the leading causes of preventable death. The costs associated with obesity are estimated at $99 million annually, comparable to the economic toll of cigarette smoking.
When it comes to being short of breath during exercise, how fat is distributed on the body is a more significant factor than overall body fatness or lung function
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dennis Michael Moore, MD 1875 Dempster, Suite 625, Park Ridge, IL 60068 Ph: (847) 518-1200 | Dr Dennis Michael Moore, MD 1875 Dempster, Suite 625, Park Ridge, IL 60068 Ph: (847) 518-1200 |
News Archive
Hospitals routinely implement processes aimed at increasing provision of high quality care for patients, such as calling patients to encourage follow-up visits or providing doctors and nurses with alerts in electronic health records to prompt reminders for vaccinations.
Dr. Bruce Bode announced today that he is now recruiting adults with newly diagnosed type 1 diabetes for Protege Encore, a randomized, placebo-controlled Phase III clinical trial. This is the second of two Phase III studies testing the safety and efficacy of an investigational drug called teplizumab. The first study, known as Protege, has completed enrollment of more than 530 subjects with type 1 diabetes.
For patients with the most common form of hepatitis C being treated for the first time, the addition of an investigational hepatitis C-specific protease inhibitor called telaprevir to the current standard therapy markedly improved their sustained viral response (SVR or viral cure) rate.
It's no secret that obesity is a major problem in America. More than one-third of adults and one-sixth of children are obese and it is one of the leading causes of preventable death. The costs associated with obesity are estimated at $99 million annually, comparable to the economic toll of cigarette smoking.
When it comes to being short of breath during exercise, how fat is distributed on the body is a more significant factor than overall body fatness or lung function
› Verified 7 days ago
Dr. Michael Layland, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1875 Dempster St, Ste 301, Park Ridge, IL 60068 Phone: 847-685-1000 Fax: 847-685-6685 | |
Dr. David P Tojo, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1875 Dempster St, Ste 301, Park Ridge, IL 60068 Phone: 847-685-1000 Fax: 847-685-6685 | |
Dr. Gregory S. Bussell, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2604 Dempster St Ste 501, Park Ridge, IL 60068 Phone: 847-674-5585 | |
Dr. Francis A. Casper, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2604 Dempster St Ste 501, Park Ridge, IL 60068 Phone: 847-674-5585 | |
Dr. Martin Emil Anderson Jr., M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2604 Dempster St Ste 501, Park Ridge, IL 60068 Phone: 847-674-5585 | |
Dr. Alexander Goldin, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1875 Dempster St, Ste 301, Park Ridge, IL 60068 Phone: 847-685-1000 Fax: 847-685-6685 |